
The Section 232 Pharmaceutical Tariff Decision: Board Governance Under Pressure
On April 2, 2026, President Trump imposed 100% tariffs on patented pharmaceuticals via Section 232, effective July 31. Boards must decide between MFN pricing agreements, domestic onshoring commitments, or accepting tariff exposure. The decision window is less than 100 d…

Mastermind Group: The Neuroscience of Executive Judgment
The quality of executive judgment is not a mystical art but a measurable cognitive function, profoundly shaped by the brain’s dual-processing systems. This Mastermind Group deep-dive explores how leaders can augment their judgment by understanding its neurological limit…

The 8-Point AI Governance Oversight Checklist for Board Directors
Board directors face mounting regulatory obligations as the EU AI Act reaches full applicability in August 2026, NIST releases updated AI governance guidance, and the SEC signals expectations for AI risk disclosure. This quick reference checklist gives directors eight c…
Why Most Boards Will Fail the 2026 AI Governance Test — And What to Do Before Proxy Season Ends
Board-level AI governance has become the defining accountability standard of the 2026 proxy season, yet fewer than one in three S&P 100 companies disclose both a board oversight structure and a formal AI policy. Institutional investors and proxy advisors are now demandi…

The Dual-Core Mandate Demands Hierarchy, Not Balance
The governance profession has long prescribed balance as the answer to the dual-core mandate, but balance is precisely the problem. Boards that govern oversight and strategy as co-equal, simultaneous priorities produce neither effective oversight nor effective strategy …

The Four-Pillar AI Governance Framework: A Visual Briefing for Board Members
AI governance is no longer optional—it’s a board imperative. The Four-Pillar Framework helps boards assess AI risk, establish governance structures, manage compliance, and capture value through a structured, board-ready model that balances oversight with innovation.